JFS Wealth Advisors’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-500
| Closed | -$2K | – | 615 |
|
|
2020
Q4 | $2K | Hold |
500
| – | – | ﹤0.01% | 535 |
|
|
2020
Q3 | $1K | Hold |
500
| – | – | ﹤0.01% | 538 |
|
|
2020
Q2 | $2K | Hold |
500
| – | – | ﹤0.01% | 494 |
|
|
2020
Q1 | $2K | Hold |
500
| – | – | ﹤0.01% | 446 |
|
|
2019
Q4 | $3K | Hold |
500
| – | – | ﹤0.01% | 434 |
|
|
2019
Q3 | $2K | Hold |
500
| – | – | ﹤0.01% | 453 |
|
|
2019
Q2 | $2K | Hold |
500
| – | – | ﹤0.01% | 437 |
|
|
2019
Q1 | $2K | Hold |
500
| – | – | ﹤0.01% | 440 |
|
|
2018
Q4 | $2K | Hold |
500
| – | – | ﹤0.01% | 426 |
|
|
2018
Q3 | $2K | Hold |
500
| – | – | ﹤0.01% | 497 |
|
|
2018
Q2 | $4K | Hold |
500
| – | – | ﹤0.01% | 414 |
|
|
2018
Q1 | $3K | Hold |
500
| – | – | ﹤0.01% | 460 |
|
|
2017
Q4 | $5K | Hold |
500
| – | – | ﹤0.01% | 431 |
|
|
2017
Q3 | $5K | Sell |
500
-500
| -50% | -$5K | ﹤0.01% | 395 |
|
|
2017
Q2 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 353 |
|
|
2017
Q1 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 384 |
|
|
2016
Q4 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 384 |
|
|
2016
Q3 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 411 |
|
|
2016
Q2 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 404 |
|
|
2016
Q1 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 429 |
|
|
2015
Q4 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 404 |
|
|
2015
Q3 | $5K | Buy |
+1,000
| New | +$5K | ﹤0.01% | 391 |
|